Intravesical urokinase for the management of clot retention in boys.
We successfully used intravesical urokinase in 2 young boys to relieve clot retention occurring as a consequence of upper tract bleeding. Urokinase clot dissolution appears to offer a simple, minimally invasive, atraumatic solution to this infrequent problem.
LaFave
M S
MS
Department of Surgery, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Decter
R M
RM
D000283:Administration, Intravesical; D002675:Child, Preschool; D004617:Embolism / Q000188:drug therapy*; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D001745:Urinary Bladder Diseases / Q000188:drug therapy* / Q000209:etiology; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D014568:Urokinase-Type Plasminogen Activator